Overview of: Douros A, Lix LM, Fralick M, et al. Sodium-glucose cotransporter-2 inhibitors and the risk for diabetic ketoacidosis. Ann Intern Med 2020;173:417-25.
Keywords: Access; Drug-Related Side Effects and Adverse Reactions; Health Care Quality; and Evaluation.
© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.